EX-10.1 — c116686_ex10-1.htm
Alvotech
SUBSCRIPTION AGREEMENT
This Subscription Agreement (the “Agreement”), dated as of [•] June 2026, is made between Alvotech, a public limited liability company (société anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registered office at 9, rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg, and registered with the Luxembourg Trade and Companies’ Register under number B258884 (the “Company”) and the undersigned investor (the “Investor”).
Background:
(A)
The Company is a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, having its shares listed on Nasdaq Iceland Main Market, Nasdaq Stock Market LLC in the USA with its ordinary shares, and Swedish Depositary Receipts on Nasdaq Stockholm.
(B)
The Company and the Investor wish to record the arrangements agreed between them in relation to the subscription for ordinary shares, USD 0.01 nominal value per share (the “Ordinary Shares”), issued by the Company.
(C)
…